Controlant announces $40 million in new financing from Apax Credit Funds
14th September 2023Apax Controlant, a global leader in real-time pharma supply chain monitoring and visibility technologies, today announced it has received $40m in financing to suppor
Controlant, a global leader in real-time pharma supply chain monitoring and visibility technologies, today announced it has received $40m in financing to support future growth from Funds advised by Apax Credit, the credit-investing arm of Apax Partners LLP (“Apax”).
Controlant is a global leader in the digital transformation of pharma supply chains. The company’s vision is to deliver zero-waste supply chains for its partners and the planet through digitalisation, automation, and transformation of the pharma supply chain. Controlant‘s holistic solution framework encompasses cloud-enabled software platform, coupled with advanced IoT devices, and cost-reducing operational services that increase supply chain efficiency and responsiveness while supporting quality, compliance, and sustainability efforts.
“As pharma companies continue to innovate at pace and introduce breakthrough medicines and vaccines, it is incredibly important that modern supply chains match this pace and serve as enablers in ensuring medicines reach patients safely, and sustainably. That is our vision, and we are working tirelessly to create the next generation of zero-waste supply chains for our pharma customers”, said Gisli Herjolfsson, CEO and co-founder, Controlant. “We are thankful for Apax Credit’s support on this journey, which will enable us to accelerate our roadmap of innovative solutions for our customers rapidly evolving and complex supply chain needs.”
The financing will help the company to accelerate growth, expand its already comprehensive and market-leading offering to global customers, and capitalise on strong tailwinds in the supply chain technology sector.
“Apax’s credit strategy provides flexible capital solutions for stand-out businesses across Apax’s four core sectors. Leveraging insights from across Apax and Apax Credit, we were pleased to provide a tailored solution for Controlant, designed to help the company in its next phase of growth”, said Albert Costa Centena, Principal, Apax Credit. “We are excited to partner with the team, leveraging our sector insights, operational expertise, and the wider Apax platform to support a business at the cutting edge of real-time visibility technology for pharma supply chains.”
- Ends -
Controlant is a global leader in the digital transformation of pharma supply chains. Our vision is to deliver zero-waste supply chains for our partners and the planet through digitalization, automation, and transformation of the pharma supply chain.
Our validated real-time visibility platform, command center, services, and advanced IoT devices, are trusted by many of the world's leading pharmaceutical and logistics companies to make their operations significantly more reliable, cost-effective, and sustainable. Ultimately, our solutions help get life-saving medicines to more patients, curing more diseases.
With over 500 employees of more than 40 nationalities, Controlant continues to expand globally. Founded in 2007 and backed by a strong investor base, Controlant generated around USD 133 million in revenues in 2022. More information at controlant.com
About Apax Credit and Apax
Established 10 years ago, Apax Credit is fully integrated into the wider Apax Platform, fully leveraging Apax’ 50 years of experience. Like the Apax Private Equity Funds, the Apax Credit Fund focuses on investments in four core sectors: Tech, Services, Healthcare and Internet/Consumer, and within each they identify attractive sub-sectors where they can offer differentiated propositions to companies, their management teams, and wider stakeholders. The Apax Credit strategy benefits from a flexible mandate, allowing the team to focus on the credit solutions that offer the best fit in each case. For further information, please visit: https://www.apax.com/create/strategies/apax-credit/
Apax Partners LLP ("Apax") is a leading global private equity advisory firm. For 50 years, Apax has worked to inspire growth and ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $65 billion. The Apax Funds invest in companies across four global sectors of Tech, Services, Healthcare, and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For further information about Apax, please visit www.apax.com.